Novo Nordisk has dropped its legal case against telehealth provider Hims & Hers over patent infringement, after the two companies agreed Hims would sell Novo’s branded medicines through its platform. “We have decided to drop the current court proceedings and, of course, we reserve to bring that back if need be, but I don’t foresee…
There was no shortage of setbacks for stocks last week. Surprising economic data, another batch of earnings, and an intensifying conflict in the Middle East all combined to move the market, mostly downward. The S & P 500 closed out Friday with a weekly loss of 2% as the broad-market index flipped between the positive…
My top 10 things to watch Wednesday, Feb. 18 1. Meta commits to buying millions of Nvidia chips for its AI data centers. It’s kind of like the old days when all of the hyperscalers clamored for Nvidia’s chips. The long knives had been out for Nvidia, but shares added almost 2% this morning. Meta was flat….
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. Stocks were rebounding to wrap up another volatile week that saw the S & P 500 still headed for losses over the past five trading days….
The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark, February 4, 2026. Tom Little | Reuters Novo Nordisk on Monday said it is suing online telehealth provider Hims & Hers for mass marketing cheaper, unapproved copies of the drugmaker’s new Wegovy obesity pill and injections in…
We get so caught up in the buzz and the sizzle that we forget about the steak, especially in this era of GLP-1s, which have revolutionized the treatment of diabetes and obesity and are being studied for so many more diseases and conditions. That’s my chief takeaway from meeting with 15 different CEOs, a dozen…
Shares of U.S. medical supplies giant Medline jumped in its debut on the Nasdaq on Wednesday after the biggest initial public offering of the year globally. The stock opened at $35, up from its $29 IPO price. Shares closed up more than 41% at $41 a share, bringing Medline’s market capitalization to roughly $54 billion….
The conundrum of the stock market going down ahead of Jackson Hole confounded me. With a market that had been headed down every day, except for deep cyclicals and housing-related stocks, the setup seemed extreme. By the end of the week, the bet was one way: Federal Reserve Chairman Jerome Powell , perhaps because he…
